热门资讯> 正文

Olema Oncology任命Jason O ' Byrne为CFO

2026-08-13 21:25

Olema Pharmaceuticals (OLMA) has appointed Jason O’Byrne as chief financial officer.
O’Byrne brings more than two decades of finance and global operations leadership across high-growth biotechnology and pharmaceutical organizations, the company said. He joins Olema from Vir Biotechnology, where he served as executive vice president and chief financial officer, leading the finance, investor relations, and information technology functions.
OLMA +2.3% to $10.68.
Source: Press Release

More on Olema Pharmaceuticals

Olema Pharmaceuticals, Inc. (OLMA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Olema: The Market Overreacted To Roche's SERD Failure
Seeking Alpha’s Quant Rating on Olema Pharmaceuticals
Historical earnings data for Olema Pharmaceuticals
Financial information for Olema Pharmaceuticals

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。